Journal of Ophthalmology

Journal of Ophthalmology / 2016 / Article
Special Issue

Multimodal Imaging in Ophthalmology

View this Special Issue

Research Article | Open Access

Volume 2016 |Article ID 1628469 |

Qingfeng Liang, Hong Liang, Hanruo Liu, Zhiqiang Pan, Christophe Baudouin, Antoine Labbé, "Ocular Surface Epithelial Thickness Evaluation in Dry Eye Patients: Clinical Correlations", Journal of Ophthalmology, vol. 2016, Article ID 1628469, 8 pages, 2016.

Ocular Surface Epithelial Thickness Evaluation in Dry Eye Patients: Clinical Correlations

Academic Editor: Taras Ardan
Received31 Oct 2015
Revised31 Dec 2015
Accepted31 Dec 2015
Published26 Jan 2016


Purpose. To evaluate the relationship between corneal and conjunctival epithelium thickness and ocular surface clinical tests in dry eye disease (DED) patients. Patients and Methods. Fifty-four patients with DED and 32 control subjects were included. Each patient underwent an ocular surface evaluation using the ocular surface disease index (OSDI), tear film break-up time (TBUT), corneal and conjunctival staining, tear film lipid layer analysis, and Schirmer test. The central corneal (CET), limbal (LET), and bulbar conjunctival epithelium thickness (BET) were acquired using spectral-domain optical coherence tomography (SD-OCT). Results. Compared to control subjects, mean BET was significantly thicker and mean LET was significantly lower in the DED group. There was no significant difference in mean CET between the two groups. The mean LET was correlated with OSDI and TBUT. The inferior LET was correlated with OSDI, Schirmer I test, TBUT, Oxford score, and corneal sensitivity. Mean BET was correlated with OSDI and TBUT, but not with Schirmer I test and Oxford score. Conclusions. In dry eye patients, a thinner limbal epithelium and a thicker bulbar conjunctival epithelium were observed. These changes were correlated to the severity of dry eye symptoms and tear film alterations.

1. Introduction

Dry eye disease (DED) is a multifactorial disease of the tears and ocular surface resulting in tear film instability with potential damage to conjunctival and corneal epithelium [1]. It results from a disturbance of the lacrimal functional unit that includes the tear film, the lacrimal and meibomian glands, the ocular surface epithelium, and the sensory and motor nerves that connect them [2]. Inflammation with inflammatory cell infiltration and cytokine production are also common features of DED, found in the lacrimal glands, the cornea, and the conjunctiva [3]. In association with the mechanical and desiccating stress induced by the lack and/or the poor quality of tears, inflammation further damages ocular surface epithelia. Considering the central role of these tissues in the pathophysiology of DED, several imaging techniques have been developed to evaluate and grade the alterations of ocular surface epithelia in vivo [4, 5]. Despite lower resolution than in vivo confocal microscopy (IVCM), SD-OCT has numerous advantages over other imaging techniques, such as slit-lamp or ultrasound biomicroscopy [6]. OCT is a noninvasive imaging method that allows high-resolution analysis and quantification without the need for ocular anesthesia or contact procedures. In a preliminary study, we used SD-OCT to noninvasively evaluate ocular surface epithelial thickness [4]. In DED patients and patients using IOP-lowering eye drops, we observed a decreased limbal-conjunctival epithelial thickness and an increased bulbar conjunctival epithelial thickness. The epithelial thickness measurement of ocular surface tissues with SD-OCT seemed to be an advantageous new parameter during ocular surface evaluation. However, the number of patients in each group was limited and correlations were not evaluated between epithelium thickness changes and ocular surface clinical tests. Thus, the objective of the present study was to compare the results of corneal, limbal, and conjunctival epithelium thicknesses obtained with SD-OCT in normal subjects and non-Sjögren dry eye patients and to evaluate the relationship between these parameters and the results of ocular surface clinical tests.

2. Patients and Methods

2.1. Subjects

This study was conducted at the Beijing Institute of Ophthalmology with approval of the Medical Ethics Committee of Beijing Tongren Hospital (TREC-2013-KY012). All patients were informed of the aims of the study and their consent was obtained according to the declaration of Helsinki. A total of 54 patients with DED not associated with Sjögren syndrome (36 women and 18 men; mean age: years; range: 24–68 years) were consecutively recruited from the Cornea Unit of Beijing Tongren Hospital from June 2013 to February 2014 (DED group). The sample size was calculated according to the results of Cui et al.’s study [7] with 80% power level. DED was defined as Schirmer I testing <5 mm and/or tear film break-up time (TBUT) <10 s, accompanied by complaints of ocular irritation in the absence of other ocular (in particular meibomian gland disease) or systemic diseases [1]. Thirty-two age- and gender-matched control subjects (20 women and 12 men; mean age: years; range: 19–67 years) were also recruited (control group). All control subjects had no complaint of ocular surface irritation and no anterior segment abnormality on biomicroscopic examination and ocular surface tests. Exclusion criteria for both groups were as follows: age <18 years, subject unable to complete the questionnaire or understand the procedures, the presence of ocular or systemic disease or the use of topical or systemic medications that may affect the cornea and the ocular surface (except the use of nonpreserved tear substitutes in the DED group), and previous eye surgery or contact lens wear.

2.2. Clinical Evaluation

Demographic information and medical history were obtained from the patients’ medical records. Each subject underwent quantification of ocular surface symptoms with the Ocular Surface Disease Index (OSDI) questionnaire (range: 0–100). Then, the subjects underwent ocular surface examinations in the following order: tear film break-up time (TBUT), corneal and conjunctival fluorescein staining, tear film lipid layer analysis, Schirmer test without anesthesia, and corneal sensation measured with the Cochet-Bonnet esthesiometer.

TBUT was measured by instilling fluorescein into the inferior cul-de-sac and calculating the average of three consecutive break-up times. Corneal and conjunctival staining was evaluated under a yellow filter using the Oxford scale and after instillation of fluorescein. Tear film lipid layer analysis was performed using interferometry (DR-1, Kowa, Tokyo, Japan) and evaluated semiquantitatively from 1 to 5 (grade 5 being the most severe) [5]. Schirmer I test was performed without anesthesia for 5 min with the patient’s eyes closed. Corneal sensation was measured using the contact nylon thread Luneau 12/100 mm Cochet-Bonnet esthesiometer (Luneau, Prunay-Le-Gillon, France) in the central cornea and in the superior, inferior, nasal, and temporal quadrants. Mean corneal sensitivity (MCS) was defined as the mean of the measures obtained in the five different areas.

2.3. SD-OCT Examination and Image Analysis

SD-OCT fitted with an anterior segment module (Optovue Corporation, Fremont, CA, USA) was used. This SD-OCT has a scan rate of 26,000 axial scans per second. Its axial and transverse optical resolution were 5 μm and 15 μm, respectively. An add-on lens (CAM-L mode: 6.0–2.0 mm) was used to assess the regional corneal and conjunctival architecture and epithelial thickness. Because SD-OCT examination is a noncontact technique, it was performed before ophthalmological examinations in order to avoid potential epithelium alterations.

The specific imaging capture technique for this study has been previously described [4]. Briefly, patients were asked to fixate on the target light source, and consecutive images were acquired with the patient’s forehead and chin stabilized by a headrest. Corneal epithelium thickness (CET) was defined as the epithelium thickness in the 2 mm central zone of the cornea; limbal epithelium thickness (LET) was defined as the limbal-conjunctival epithelium thickness in each quadrant (superior, inferior, temporal, and nasal); bulbar conjunctival epithelial thickness (BET) was defined as the bulbar conjunctival epithelial thickness located between 2 and 3 mm from the limbus of each quadrant (Figure 1).

The cursors were placed perpendicular to the ocular surface epithelium from a point located just beneath the tear film (first hyperreflective layer) to the basal membrane (second hyperreflective layer). For every quadrant, three measurements were taken (if the difference between measurements exceeded 3 μm, the measurement was repeated in order to confirm thickness measurement reproducibility; the measurement needed to be confirmed in less than 5% of cases), and the results were expressed as mean ± SD. The measurements were taken by one researcher (HL) who was masked to patient demographic data and the results of ophthalmologic examinations. To evaluate interobserver variability, a second examiner (QL), who was masked to the results of the first SD-OCT analyses, assessed CET, LET, and BET from the same images of 20 randomized patients.

2.4. Statistical Analysis

Statistical analyses were performed with SPSS for Windows version 16.0 (SPSS Inc., Chicago, IL, USA). For each patient, one eye was randomly chosen for statistical analysis. The mean ± SD values of each epithelial thickness variable were calculated for both the DED and control groups. To compare ocular surface parameters and epithelial thickness, measured in normal and DED eyes, two-tailed Student’s -tests were performed. The Pearson correlation coefficient was used in DED patients to investigate the correlation between the quantitative measurements of epithelial thicknesses and the results of other ocular surface evaluations. values less than 0.05 were considered statistically significant.

3. Results

There was no difference in terms of gender () and age () between the DED and control groups. Concerning ocular surface clinical evaluation, DED patients had significantly more symptoms (OSDI) ( versus , ), lower TBUT ( s versus  s, ), a lower Schirmer I test score ( mm versus  mm, ), and a higher Oxford score ( versus 0.00, ) as compared to the control group. Mean corneal sensitivity was significantly decreased in the DED group ( mm versus  mm, ), while tear film lipid layer interferometry was not statistically different between the two groups ( mm versus .52, ). Results of clinical data are presented in Table 1.

ParametersDED groupControl groupvalue

Number of patients5432
 Female36 (66.7%)20 (62.5%)0.699
 Male18 (33.3%)12 (37.5%)
Age (years)44.59 10.0843.34 10.810.503
OSDI35.46 14.941.52 3.96<0.001
Schirmer I test (mm)4.11 6.9812.56 6.99<0.001
TBUT (seconds)4.67 2.3013.31 2.54<0.001
Oxford scale1.06 1.730.00 0.000.001
MCS (mm)5.74 0.415.98 0.070.002
TFL2.43 0.712.28 0.520.323

DED: dry eye disease; OSDI: Ocular Surface Disease Index; TBUT: tear film break-up time; MCS: mean corneal sensitivity; TFL: tear film lipid layer interferometry.

Mean CET, LET, and BET were μm, μm, and μm in the DED group and μm, μm, and μm in the control group, respectively. Compared to control subjects, mean BET was significantly thicker () and mean LET was significantly lower () in the DED group. There was no significant difference in CET between the two groups (). In addition, dry eyes had a significantly thicker BET in each quadrant region (superior, ; inferior, ; temporal, ; and nasal, ) than that of normal subjects. In dry eyes, the LET was also significantly thinner in the inferior (), temporal (), and nasal regions () but not in the superior region () as compared to control subjects (Table 2, Figure 2).

ParametersDED groupControl group value

Number of patients5432
CET50.23 4.4249.76 3.150.103
LET81.37 6.2187.14 9.980.009
 LET (N)80.60 9.2789.95 15.23<0.001
 LET (T)80.73 8.9187.65 11.190.008
 LET (S)82.10 8.4884.64 6.750.152
 LET (I)80.12 7.8486.74 14.450.011
BET50.44 5.2544.62 5.04<0.001
 BET (N)50.99 5.2643.45 4.990.003
 BET (T)50.37 6.1442.57 5.00<0.001
 BET (S)50.10 5.1343.99 5.540.005
 BET (I)51.35 5.2746.48 8.830.014

CET: corneal epithelium thickness; LET: limbal epithelium thickness; BET: bulbar conjunctival epithelium thickness; N: nasal; T: temporal; S: superior; I: inferior.

Within the DED group, there were significant correlations between symptoms (OSDI) and Schirmer I test (, ), TBUT (, ), and Oxford score (, ). TBUT was also correlated with Schirmer I test and Oxford score (, and , , resp.). Tear film lipid layer interferometry was correlated with TBUT, Oxford score, and MCS (, ; , ; and , , resp.) (Table 3).

ParametersGenderAgeOSDISchirmer 1 testTBUTOxford scaleMCS

Schirmer 1 test
Oxford scale

DED: dry eye disease; OSDI: Ocular Surface Disease Index; TBUT: tear film break-up time; MCS: mean corneal sensitivity; TFL: tear film lipid layer interferometry.

When evaluating the relationship between dry eye clinical tests and ocular surface epithelium thickness parameters, mean BET was correlated with OSDI (, ) and TBUT (, ) but not with Schirmer I test (, ) and Oxford score (, ). The mean LET was correlated with OSDI and TBUT (, and , , resp.). Interestingly, the inferior quadrant LET was correlated with OSDI (, ), Schirmer I test (, ), TBUT (, ), Oxford score (, ), and MCS (, ) (Table 4).

ParametersGenderAgeOSDISchirmer I testTBUTOxford scaleMCSTFL

LET (nasal)
LET (temporal)
LET (superior)
LET (inferior)
BET (nasal)
BET (temporal)
BET (superior)
BET (inferior)

DED: dry eye disease; OSDI: Ocular Surface Disease Index; TBUT: tear film break-up time; MCS: mean corneal sensitivity; TFL: tear film lipid layer interferometry; CET: corneal epithelium thickness; LET: limbal epithelium thickness; BET: bulbar conjunctival epithelium thickness.

4. Discussion

Several studies have been conducted to measure the thickness and morphology of ocular surface epithelium with OCT, IVCM, or ultrasound, in order to better understand epithelial alterations in DED [713]. With Fourier-domain OCT, Cui et al. evaluated for the first time the features of the corneal epithelial thickness map within the central 5 mm zone and the correlation with symptoms in dry eye patients [7]. Yang et al. [14] and our group [4] reported the evaluation with SD-OCT of ocular surface epithelia including the bulbar conjunctival epithelium, the limbal epithelium, and the central corneal epithelium thicknesses in normal subjects and dry eye patients. However, no studies reported the correlations between DED clinical features and ocular surface epithelial thicknesses, including the limbal and the conjunctival epithelium. In accordance with our previous results [4], we observed a thinner limbal epithelium and a thicker conjunctival epithelium in patients with dry eye. Moreover, we observed that the severities of symptoms (OSDI) and tear film alterations (TBUT) were correlated to both LET and BET.

When evaluating the CET of DED patients, some authors observed a decrease, while others found no change or even an increase as compared with the control group [4, 7, 8, 15]. Comparison between studies was made difficult by the different durations and severities of the disease, the varying ages of DED patients, and the different techniques used to measure CET. Fabiani et al. [15] established a mouse model of dry eye and detected that the average CET became significantly thicker in dry eye mice as compared to the controls after 7 days. These results demonstrated that the inflammatory processes and epithelial proliferation had a significant impact on the average CET in the early stage of DED. The studies from Chen et al. [16] and Kanellopoulos and Asimellis [17] indicated that increased epithelial thickness might be used as an objective clinical indicator of dry eye. Conversely, Cui et al. [7] found that the superior corneal epithelium was thinner in DED patients than in normal subjects. Erdélyi et al. [18] and Villani et al. [19] also showed that the CET tends to be thinner in DED patients, which was attributed to the destruction of stem cells at the limbus. In the present study, there was no significant difference in CET between DED patients and the control group, consistent with our previous results [4] and the results from Tuominen et al. [20]. This may be explained by the moderate severity of DED (average OSDI 35.46 and TBUT 4.67 s) and the location of CET evaluation in the central cornea (central 2 mm diameter area), away from the limbus.

Considering the role of limbal epithelial stem cells (LESCs) in corneal epithelium homeostasis, the limbal region is essential in dry eye physiopathology [21]. Several factors might explain the reduced thickness of the limbal epithelium in DED. First, stem cell metabolism can be directly affected in DED patients [2224]. Infiltration of T cells at the limbus and the levels of inflammatory cytokines in tears may play an important role in inhibiting corneoscleral stem cell metabolism in dry eye patients. This downregulation of limbal stem cells in DED patients could influence the development of corneal limbal epithelial layers and result in a thinner LET. Increased turnover of corneal epithelial cells might also explain limbal epithelial cell depletion in DED [4]. Limbal microenvironment inflammation could also directly alter limbal stem cells and their functions, resulting in various degrees of stem cell deficiency [25]. The inferior and superior limbal areas are thought to be the largest reservoirs of limbal stem cells as compared to the nasal and temporal quadrants. With confocal microscopy and scanning electron microscopy, Shortt et al. [26] showed more limbal crypts in the superior and inferior limbal regions. Similarly, Thoft et al. found a larger number of stem cells in the superior and inferior limbus than in the medial and lateral areas [27]. Interestingly, in the present study, the inferior LET seemed to be the most sensitive parameter because it was directly correlated to the OSDI, the Schirmer test, TBUT, the Oxford score, and mean corneal sensitivity. The greatest changes observed for the inferior LET could be explained by the prolonged contact between epithelial cells and altered tears within the inferior lacrimal river containing inflammatory factors such as cellular debris or proinflammatory cytokines. Decreased corneal sensitivity correlated to the inferior LET was also observed in DED patients. Corneal nerves are implicated in DED pathophysiology and DED patients exhibit nerves alterations [5]. These nerves changes have been correlated to the severity of the ocular surface lesions and might be in part responsible for corneal sensitivity alterations. As observed with corneal nerves, a thinner inferior LET might represent a marker of DED severity and emphasized the role of LESCs in ocular surface diseases.

The bulbar conjunctiva is an essential tissue of the ocular surface with numerous ocular surface cell populations including inflammatory cells and goblet cells [28, 29]. In this study, the mean BET in dry eye patients was significantly increased as compared to normal eyes. Moreover, the thickness of the conjunctival epithelium layers was directly correlated to symptoms (OSDI) and tear film alterations (TBUT). The infiltration of inflammatory cells and tissue edema observed within the conjunctiva in DED patients might explain, at least in part, the thickening of the conjunctival epithelium [30].

Although the changes in ocular surface epithelium thickness evaluated with SD-OCT are not specific of a particular etiology of DED and may also be observed in other ocular surface diseases, this parameter is providing useful information for the evaluation of ocular surface tissue changes. Given that it is already used for the evaluation of keratoconus, ocular surface epithelial mapping, especially corneal limbus epithelial mapping, might be used in association with other clinical parameters to monitor DED ocular surface changes and the benefit of different treatments in the future.

Conflict of Interests

No conflicting relationship exists for any author.


This study is supported by the Central Health Research Project Fund (W2013BJ47), China.


  1. “The definition and classification of dry eye disease: report of the definition and classification subcommittee of the international Dry Eye WorkShop (2007),” Ocular Surface, vol. 5, no. 2, pp. 75–92, 2007. View at: Publisher Site | Google Scholar
  2. M. E. Stern, R. W. Beuerman, R. I. Fox, J. Gao, A. K. Mircheff, and S. C. Pflugfelder, “The pathology of dry eye: the interaction between the ocular surface and lacrimal glands,” Cornea, vol. 17, no. 6, pp. 584–589, 1998. View at: Publisher Site | Google Scholar
  3. Y. Wei and P. A. Asbell, “The core mechanism of dry eye disease is inflammation,” Eye and Contact Lens, vol. 40, no. 4, pp. 248–256, 2014. View at: Publisher Site | Google Scholar
  4. M. Francoz, I. Karamoko, C. Baudouin, and A. Labbé, “Ocular surface epithelial thickness evaluation with spectral-domain optical coherence tomography,” Investigative Ophthalmology & Visual Science, vol. 52, no. 12, pp. 9116–9123, 2011. View at: Publisher Site | Google Scholar
  5. A. Labbé, Q. Liang, Z. Wang et al., “Corneal nerve structure and function in patients with non-sjögren dry eye: clinical correlations,” Investigative Ophthalmology and Visual Science, vol. 54, no. 8, pp. 5144–5150, 2013. View at: Publisher Site | Google Scholar
  6. A. Yagci and C. Gurdal, “The role and treatment of inflammation in dry eye disease,” International Ophthalmology, vol. 34, no. 6, pp. 1291–1301, 2014. View at: Publisher Site | Google Scholar
  7. X. Cui, J. Hong, F. Wang et al., “Assessment of corneal epithelial thickness in dry eye patients,” Optometry & Vision Science, vol. 91, no. 12, pp. 1446–1454, 2014. View at: Publisher Site | Google Scholar
  8. D. Z. Reinstein, T. E. Yap, T. J. Archer, M. Gobbe, and R. H. Silverman, “Comparison of corneal epithelial thickness measurement between fourier-domain OCT and very high-frequency digital ultrasound,” Journal of Refractive Surgery, vol. 31, no. 7, pp. 438–445, 2015. View at: Publisher Site | Google Scholar
  9. K.-S. Na, J.-W. Mok, J. Y. Kim, C. R. Rho, and C.-K. Joo, “Correlations between tear cytokines, chemokines, and soluble receptors and clinical severity of dry eye disease,” Investigative Ophthalmology & Visual Science, vol. 53, no. 9, pp. 5443–5450, 2012. View at: Publisher Site | Google Scholar
  10. A. Alhatem, B. Cavalcanti, and P. Hamrah, “In vivo confocal microscopy in dry eye disease and related conditions,” Seminars in Ophthalmology, vol. 27, no. 5-6, pp. 138–148, 2012. View at: Publisher Site | Google Scholar
  11. J. A. Hallak, S. Jassim, V. Khanolkar, and S. Jain, “Symptom burden of patients with dry eye disease: a four domain analysis,” PLoS ONE, vol. 8, no. 12, Article ID e82805, 2013. View at: Publisher Site | Google Scholar
  12. G. Cardona, C. García, C. Serés, M. Vilaseca, and J. Gispets, “Blink rate, blink amplitude, and tear film integrity during dynamic visual display terminal tasks,” Current Eye Research, vol. 36, no. 3, pp. 190–197, 2011. View at: Publisher Site | Google Scholar
  13. K. S. Na, K. Han, Y. G. Park, C. Na, and C. K. Joo, “Depression, stress, quality of life, and dry eye disease in Korean women: a population-based study,” Cornea, vol. 34, no. 7, pp. 733–738, 2015. View at: Publisher Site | Google Scholar
  14. Y. Yang, J. Hong, S. X. Deng, and J. Xu, “Age-related changes in human corneal epithelial thickness measured with anterior segment optical coherence tomography,” Investigative Ophthalmology and Visual Science, vol. 55, no. 8, pp. 5032–5038, 2014. View at: Publisher Site | Google Scholar
  15. C. Fabiani, S. Barabino, S. Rashid, and M. R. Dana, “Corneal epithelial proliferation and thickness in a mouse model of dry eye,” Experimental Eye Research, vol. 89, no. 2, pp. 166–171, 2009. View at: Publisher Site | Google Scholar
  16. W. Chen, Z. Li, J. Hu et al., “Corneal alternations induced by topical application of benzalkonium chloride in rabbit,” PLoS ONE, vol. 6, no. 10, Article ID e26103, 2011. View at: Publisher Site | Google Scholar
  17. A. J. Kanellopoulos and G. Asimellis, “In vivo 3-dimensional corneal epithelial thickness mapping as an indicator of dry eye: preliminary clinical assessment,” American Journal of Ophthalmology, vol. 157, no. 1, pp. 63.e2–68.e2, 2014. View at: Publisher Site | Google Scholar
  18. B. Erdélyi, R. Kraak, A. Zhivov, R. Guthoff, and J. Németh, “In vivo confocal laser scanning microscopy of the cornea in dry eye,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 245, no. 1, pp. 39–44, 2007. View at: Publisher Site | Google Scholar
  19. E. Villani, D. Galimberti, F. Viola, C. Mapelli, and R. Ratiglia, “The cornea in Sjögren's syndrome: an in vivo confocal study,” Investigative Ophthalmology and Visual Science, vol. 48, no. 5, pp. 2017–2022, 2007. View at: Publisher Site | Google Scholar
  20. I. S. J. Tuominen, Y. T. Konttinen, M. H. Vesaluoma, J. A. O. Moilanen, M. Helintö, and T. M. T. Tervo, “Corneal innervation and morphology in primary Sjögren's syndrome,” Investigative Ophthalmology and Visual Science, vol. 44, no. 6, pp. 2545–2549, 2003. View at: Publisher Site | Google Scholar
  21. M. Dogru and K. Tsubota, “New insights into the diagnosis and treatment of dry eye,” Ocular Surface, vol. 2, no. 2, pp. 59–75, 2004. View at: Publisher Site | Google Scholar
  22. L. S. Vera, J. Gueudry, A. Delcampe, J.-C. Roujeau, G. Brasseur, and M. Muraine, “In vivo confocal microscopic evaluation of corneal changes in chronic Stevens-Johnson syndrome and toxic epidermal necrolysis,” Cornea, vol. 28, no. 4, pp. 401–407, 2009. View at: Publisher Site | Google Scholar
  23. B. Steger, L. Speicher, W. Philipp, and N. E. Bechrakis, “In vivo confocal microscopic characterisation of the cornea in chronic graft-versus-host disease related severe dry eye disease,” British Journal of Ophthalmology, vol. 99, no. 2, pp. 160–165, 2015. View at: Publisher Site | Google Scholar
  24. M. J. Lee, A. Y. Ko, J. H. Ko et al., “Mesenchymal stem/stromal cells protect the ocular surface by suppressing inflammation in an experimental dry eye,” Molecular Therapy, vol. 23, no. 1, pp. 139–146, 2015. View at: Publisher Site | Google Scholar
  25. C. Baudouin, “A new approach for better comprehension of diseases of the ocular surface,” Journal Français d'Ophtalmologie, vol. 30, pp. 239–246, 2007. View at: Google Scholar
  26. A. J. Shortt, S. J. Tuft, and J. T. Daniels, “Corneal stem cells in the eye clinic,” British Medical Bulletin, vol. 100, no. 1, pp. 209–225, 2011. View at: Publisher Site | Google Scholar
  27. R. A. Thoft, L. A. Wiley, and N. Sundarraj, “The multipotential cells of the limbus,” Eye, vol. 3, no. 2, pp. 109–113, 1989. View at: Publisher Site | Google Scholar
  28. J. T. Henriksson, C. S. De Paiva, W. Farley, S. C. Pflugfelder, A. R. Burns, and J. P. G. Bergmanson, “Morphologic alterations of the palpebral conjunctival epithelium in a dry eye model,” Cornea, vol. 32, no. 4, pp. 483–490, 2013. View at: Publisher Site | Google Scholar
  29. P. Argüeso, M. Balaram, S. Spurr-Michaud, H. T. Keutmann, M. R. Dana, and I. K. Gipson, “Decreased levels of the goblet cell mucin MUC5AC in tears of patients with Sjögren syndrome,” Investigative Ophthalmology & Visual Science, vol. 43, no. 4, pp. 1004–1011, 2002. View at: Google Scholar
  30. P. Chhadva, A. Alexander, A. L. McClellan et al., “The impact of conjunctivochalasis on dry eye symptoms and signs,” Investigative Ophthalmology & Visual Science, vol. 56, no. 5, pp. 2867–2871, 2015. View at: Publisher Site | Google Scholar

Copyright © 2016 Qingfeng Liang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles